Titan Pharmaceuticals Inc (TTNP)
3.92
-0.11
(-2.73%)
USD |
NASDAQ |
Nov 05, 09:47
Titan Pharmaceuticals Price to Book Value: 0.8975 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 0.9227 |
| November 01, 2024 | 0.9169 |
| October 31, 2024 | 0.9135 |
| October 30, 2024 | 0.9273 |
| October 29, 2024 | 0.9044 |
| October 28, 2024 | 0.8746 |
| October 25, 2024 | 0.8824 |
| October 24, 2024 | 0.907 |
| October 23, 2024 | 0.9845 |
| October 22, 2024 | 0.9914 |
| October 21, 2024 | 1.049 |
| October 18, 2024 | 1.097 |
| October 17, 2024 | 1.088 |
| October 16, 2024 | 1.108 |
| October 15, 2024 | 1.076 |
| October 14, 2024 | 1.116 |
| October 11, 2024 | 1.140 |
| October 10, 2024 | 1.122 |
| October 09, 2024 | 1.145 |
| October 08, 2024 | 1.168 |
| October 07, 2024 | 1.152 |
| October 04, 2024 | 1.213 |
| October 03, 2024 | 1.219 |
| October 02, 2024 | 1.200 |
| October 01, 2024 | 1.192 |
| Date | Value |
|---|---|
| September 30, 2024 | 1.207 |
| September 27, 2024 | 1.255 |
| September 26, 2024 | 1.204 |
| September 25, 2024 | 1.188 |
| September 24, 2024 | 1.156 |
| September 23, 2024 | 1.21 |
| September 20, 2024 | 1.296 |
| September 19, 2024 | 1.273 |
| September 18, 2024 | 1.296 |
| September 17, 2024 | 1.339 |
| September 16, 2024 | 1.321 |
| September 13, 2024 | 1.268 |
| September 12, 2024 | 1.266 |
| September 11, 2024 | 1.289 |
| September 10, 2024 | 1.290 |
| September 09, 2024 | 1.319 |
| September 06, 2024 | 1.312 |
| September 05, 2024 | 1.353 |
| September 04, 2024 | 1.353 |
| September 03, 2024 | 1.310 |
| August 30, 2024 | 1.404 |
| August 29, 2024 | 1.297 |
| August 28, 2024 | 1.406 |
| August 27, 2024 | 1.541 |
| August 26, 2024 | 1.465 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.478
Minimum
Dec 21 2023
23.81
Maximum
Mar 02 2020
4.610
Average
2.436
Median
Aug 25 2021
Price to Book Value Benchmarks
| AIM ImmunoTech Inc | 2.666 |
| Perspective Therapeutics Inc | 2.412 |
| Protalix BioTherapeutics Inc | 3.294 |
| Electromed Inc | 4.416 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| Price | 3.92 |
| Earnings Yield | -166.8% |
| Market Cap | 3.584M |